Abstract
Assay of fractions obtained from ion exchange chromatography of papaya latex on CM Sephadex-C50, size exclusion chromatography on Sephacryl S-300 and size exclusion HPLC have provided an insight into the relative contributions of the gluten-detoxifying enzymes present. This outcome has been achieved by the use of the above chromatographic techniques, coupled with assays of lysosomal activity, protease activity using benzylarginine ethyl ester (BAEE) as substrate, prolyl endopeptidase (PEP) using glycylprolylnitroanilide and a prolidase assay using acetylprolylglycine. These procedures have shown that the activity in papaya latex is due largely to caricain and to a lesser extent, chymopapain and glutamine cyclotransferase. The presence of caricain and these other enzymes was confirmed by mass spectrometry of trypsin digests of the most active fraction obtained by CM Sephadex-C50 chromatography and size exclusion HPLC. Fractions rich in caricain would be suitable for enzyme therapy in gluten intolerance and appear to have synergistic action with porcine intestinal extracts.
Similar content being viewed by others
References
Arnon R (1970) The cysteine proteases: papain. Methods Enzymol 19:226–244
Auricchio S, Cardelli M, De Ritis G, De Vincenzi M, Lattes F, Silvano V (1984) An in vitro animal model for the study of cereal components toxic in coeliac disease. Pediatr Res 18:1372–1378
Cornell HJ (1998) Partial in vitro digestion of active gliadin-related peptides in coeliac disease. J Protein Chem 17:739–744
Cornell HJ (2005) The aetiology of coeliac disease and its significance for therapy. Curr Top Pept Protein Res 7:17–21
Cornell HJ, Townley RRW (1973) The effect of gliadin peptides on rat liver lysosomes in relation to the pathogenesis of coeliac disease. Clin Chim Acta 49:181–188
Cornell HJ, Mothes T (1993) The activity of wheat gliadin peptides in in vitro assays for coeliac disease. Biochim Biophys Acta 1181:169–173
Cornell HJ, Mothes (1995) Further studies of the in vitro activity of synthetic gliadin peptides in coeliac disease. Biochim Biophys Acta 1270:168–172
Cornell HJ, Rivett DE (1995) In vitro mucosal digestion of synthetic gliadin-derived peptides in coeliac disease. J Protein Chem 14:335–339
Cornell HJ, Stelmasiak T (2004) Enzyme supplementation in coeliac disease. In: The 11th international symposium on coeliac disease, Belfast, Northern Ireland, April 28–30, p 196
Cornell HJ, Stelmasiak T (2007) A unified hypothesis of coeliac disease with implications for management of patients. Amino Acids 33:43–49
Cornell HJ, Macrae FA, Melny J, Pizzey C, Cook F, Mason S, Bhathal P, Stelmasiak T (2005) Enzyme therapy for management of coeliac disease. Scand J Gastroenterol 40:1304–1312
Dubey VK, Pande M, Singh BK, Jagannadham MV (2007) Papain-like proteases: applications of their inhibitors. Afr J Biotechnol 6:1077–1086
Ebata M, Yasunobu KT (1962) Chymopapain. I. Isolation, crystallization and preliminary characterization. J Biol Chem 237:1086–1094
Groves MR, Taylor MA, Scott M, Cummings NJ, Pickersgill RW, Jenkins JA (1996) The prosequence of procaricain forms and alpha-helical domain that prevents access to the substrate-binding cleft. Structure 4:1193–1203
Ikeuchi Y, Katerelos NA, Goodenough PW (1998) The enhancing of a cysteine proteinase activity at acidic pH by protein engineering, the role of glutamic 50 in the enzyme mechanism of caricain. FEBS Lett 437:91–96
Kocna P, Frič P (1980) Endopeptidase of the brush border membrane of Rat Enterocyte. Hoppe-Seyler’s Z Physiol Chem 361:1401–1412
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
McLachlan A, Cullis PG, Cornell HJ (2002) The use of extended motifs for focussing on toxic peptides in coeliac disease. J Biochem Mol Biol Biophys 6:319–324
Maurer HR (2001) Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 58:1234–1245
Messer M, Baume PE (1976) Oral papain in gluten intolerance. Lancet ii:1022
Messer M, Anderson CM, Hubbard L (1964) Studies on the mechanism of destruction of the toxic action of wheat gluten in coeliac disease by crude papain. Gut 5:295–303
Oberg KA, Ruysschaert J-M, Azarkan M, Smolders N, Zerhouni N, Wintjens R, Amrani A, Looze Y (1998) Papaya glutamine cyclase, a plant enzyme highly resistant to proteolysis, adopts an all-β conformation. Eur J Biochem 258:214–222
Prabucka B, Bielawski W (2004) Purification and partial characterisation of a major gliadin-degrading cysteine endopeptidase from germinating triticale seeds. Acta Physiol Plant 26:383–392
Robyt JF, White BJ (1987) Biochemical techniques—theory and practice. Brooks/Cole Publishing Company, California, pp 151–155
Sjöström H, Norem O, Josefsson L (1973) Purification and specificity of pig intestinal prolidase. Biochim Biophys Acta 327:457–470
Szeltner Z, Renner V, Polgar L (2000) Substrate and pH dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family. Protein Sci 9:353–360
Szwajcer-Dey E, Rasmussen J, Meldal M, Breddam K (1992) Proline-specific endopeptidases from microbial sources: isolation of an enzyme from xanthomonas sp. J Bacteriol 174:2454–2459
Zerhouni S, Amrani A, Nijs M, Smolders N, Azarkan M, Vincentelli J, Looze Y (1998) Purification and characterization of papaya glutamine cyclotransferase, a plant enzyme highly resistant to chemical acid and thermal denaturation. BBA 1387:275–290
Acknowledgments
The authors acknowledge the generosity of Glutagen Pty Ltd for funding to allow most of this work to be carried out at Bio 21 Institute, Parkville. They are also grateful to Dr. Paul O’Donnell for conducting the mass spectrometry there and to Dr. Denis Scanlon for expert assistance with the HPLC. We are also grateful to Dr. Robert Moritz of the Ludwig Institute For Cancer Research, Parkville, Australia, for the MS analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cornell, H.J., Doherty, W. & Stelmasiak, T. Papaya latex enzymes capable of detoxification of gliadin. Amino Acids 38, 155–165 (2010). https://doi.org/10.1007/s00726-008-0223-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-008-0223-6